Clinical Trial Update: Feasibility Study of PID Versus MPC and HMS [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase feasibility trial comparing PID, MPC, and HMS therapies for Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Type 1 Diabetes Mellitus | EARLY_Phase 1 | Status: COMPLETED